Sage Journals: Discover world-class research

Abstract

Purpose

Patient-centric methods to support diabetes management are important to overcome barriers associated with initiating mealtime insulin. This article describes the subject-driven titration tools implemented in the AUTONOMY trial to initiate and adjust mealtime insulin dose and the methods used to apply these tools in clinical practice.

Conclusions

The methods used to initiate and escalate mealtime insulin in the AUTONOMY trial proved to be safe and effective, and the patient-friendly guide to self-adjusting mealtime insulin dose may mitigate the complexities associated with treatment intensification while empowering patients to reach their glycemic goals.

Get full access to this article

View all access options for this article.

References

Joy

. Clinical pearls and strategies to optimize patient outcomes. Diabetes Educ. 2008;34(suppl 3):54S-59S.

Meece

. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ. 2006;32(suppl 1):9S-18S.

Siminerio

Zgibor

Solano

. Implementing the chronic care model for improvements in diabetes practice and outcomes in primary care: the University of Pittsburgh Medical Center experience. Clin Diabetes. 2004;22(2):54-58.

Rodbard

Visco

Andersen

Hiort

Shu

. Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial. Lancet Diabetes Endocrinol. 2014;2(1):30-37.

Edelman

Liu

Johnson

Glass

. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care. 2014;37(8):2132-2140.

Harris

Yale

Berard

. Does a patient-managed insulin intensification strategy with insulin glargine and insulin glulisine provide similar glycemic control as a physician-managed strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study: a randomized noninferiority trial. Diabetes Care. 2014;37(3):604-610.

Edelman

Pettus

. Challenges associated with insulin therapy in type 2 diabetes mellitus. Am J Med. 2014;127(suppl 10):S11-S16.

Brod

Alolga

Meneghini

. Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities. Patient. 2014;7(4):437-450.

World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997;277(11):925-926.

10.

Powers

Bardsley

Cypress

. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Educ. 2015;41:417-430.

11.

Miccoli

Penno

Del Prato

. Multidrug treatment of type 2 diabetes: a challenge for compliance. Diabetes Care. 2011;34(suppl 2):S231-S235.

12.

Phillips

Branch

Cook

. Clinical inertia. Ann Intern Med. 2001;135(9):825-834.

13.

Hunt

Valenzuela

Pugh

. NIDDM patients’ fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care. 1997;20(3):292-298.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

52.75 MB

0.00 MB